LLY

898.5

-1.78%↓

JNJ

239.25

-0.3%↓

ABBV

211.26

+2.28%↑

NVS

149.54

-0.8%↓

MRK

118.94

-0.3%↓

LLY

898.5

-1.78%↓

JNJ

239.25

-0.3%↓

ABBV

211.26

+2.28%↑

NVS

149.54

-0.8%↓

MRK

118.94

-0.3%↓

LLY

898.5

-1.78%↓

JNJ

239.25

-0.3%↓

ABBV

211.26

+2.28%↑

NVS

149.54

-0.8%↓

MRK

118.94

-0.3%↓

LLY

898.5

-1.78%↓

JNJ

239.25

-0.3%↓

ABBV

211.26

+2.28%↑

NVS

149.54

-0.8%↓

MRK

118.94

-0.3%↓

LLY

898.5

-1.78%↓

JNJ

239.25

-0.3%↓

ABBV

211.26

+2.28%↑

NVS

149.54

-0.8%↓

MRK

118.94

-0.3%↓

Search

Quanterix Corp

Închisă

SectorSănătate

3.89 -0.77

Rezumat

Modificarea prețului

24h

Curent

Minim

3.8

Maxim

4.08

Indicatori cheie

By Trading Economics

Venit

10M

-23M

Vânzări

3.7M

44M

Marjă de profit

-52.712

Angajați

450

EBITDA

15M

-17M

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+89.39% upside

Dividende

By Dow Jones

Următoarele câștiguri

11 mai 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

-111M

185M

Deschiderea anterioară

4.66

Închiderea anterioară

3.89

Sentimentul știrilor

By Acuity

50%

50%

164 / 349 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Neutral Evidence

Quanterix Corp Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

26 mar. 2026, 23:43 UTC

Market Talk

Nikkei May Decline Amid Uncertainty Over Iran Peace Talks -- Market Talk

26 mar. 2026, 23:36 UTC

Market Talk
Evenimente importante

Gold Rises Amid Signs of Easing Middle East Tensions -- Market Talk

26 mar. 2026, 23:35 UTC

Achiziții, Fuziuni, Preluări

Pernod Ricard: Confirms Discussions With Brown-Forman

26 mar. 2026, 23:29 UTC

Câștiguri

Haier Smart Home: Company to Finance Share Buybacks Via Internal Funds >600690.SH

26 mar. 2026, 23:28 UTC

Câștiguri

Haier Smart Home Plans A Share Buybacks of CNY3.0B-CNY6.0B >600690.SH

26 mar. 2026, 23:28 UTC

Câștiguri

Haier Smart Home Plans to Increase Payout Ratio to 60% for 2027, 2028 >600690.SH

26 mar. 2026, 23:28 UTC

Câștiguri

Haier Smart Home Plans Cash Dividend Payout Ratio of Up to 58% for 2026 >600690.SH

26 mar. 2026, 23:27 UTC

Câștiguri

Haier Smart Home 2025 Net CNY19.55B Vs. Net CNY18.73B >600690.SH

26 mar. 2026, 23:27 UTC

Câștiguri

Haier Smart Home 2025 Rev CNY302.33B Vs. CNY286.01B >600690.SH

26 mar. 2026, 23:08 UTC

Market Talk

Infratil's Investor Day Addresses Data-Center Issues -- Market Talk

26 mar. 2026, 23:04 UTC

Achiziții, Fuziuni, Preluări

Pernod Ricard in Talks to Combine With Jack Daniel's Maker Brown-Forman -- WSJ

26 mar. 2026, 23:04 UTC

Achiziții, Fuziuni, Preluări

Families Behind Pernod, Brown-Forman Would Each Likely Retain Significant Stakes, Source Says -- WSJ

26 mar. 2026, 23:04 UTC

Achiziții, Fuziuni, Preluări

Pernod, Brown-Forman Discussing Mostly Stock Deal, Source Says -- WSJ

26 mar. 2026, 23:04 UTC

Achiziții, Fuziuni, Preluări

Pernod-Brown-Forman Deal Announcement Could Be Weeks Away, Sources Say -- WSJ

26 mar. 2026, 23:04 UTC

Achiziții, Fuziuni, Preluări

Pernod in Deal Talks With Brown-Forman -- WSJ

26 mar. 2026, 22:41 UTC

Achiziții, Fuziuni, Preluări

Brown-Forman: No Agreement Has Been Reached as to Terms of Any Possible Pernod Ricard Transaction

26 mar. 2026, 22:41 UTC

Achiziții, Fuziuni, Preluări

Brown-Forman: Synergies From Contemplated Pernod Ricard Combination Expected to Be Significant

26 mar. 2026, 22:26 UTC

Câștiguri

Jiangxi Copper 2025 Rev CNY544.62B Vs. CNY516.61B >0358.HK

26 mar. 2026, 22:26 UTC

Câștiguri

Jiangxi Copper 2025 Net CNY7.13B Vs. Net CNY6.96B >0358.HK

26 mar. 2026, 22:26 UTC

Câștiguri

Jiangxi Copper Higher Demand For Products Supported Results>0358.HK

26 mar. 2026, 22:08 UTC

Câștiguri

Air China 2025 Loss CNY1.79B Vs. Loss CNY232.56M >0753.HK

26 mar. 2026, 22:08 UTC

Câștiguri

Air China Impairment Loss on Goodwill Weighed on Results>0753.HK

26 mar. 2026, 22:08 UTC

Câștiguri

Air China 2025 Rev CNY171.48B Vs. CNY166.70B >0753.HK

26 mar. 2026, 22:07 UTC

Market Talk
Evenimente importante

Global Energy Roundup: Market Talk

26 mar. 2026, 22:07 UTC

Market Talk
Evenimente importante

Open-Pit Gold Miners Most Exposed to High Fuel Prices -- Market Talk

26 mar. 2026, 22:00 UTC

Câștiguri

Tsingtao Brewery 2025 Net CNY4.59B Vs. Net CNY4.34B >0168.HK

26 mar. 2026, 22:00 UTC

Câștiguri

Tsingtao Brewery: Higher Volume Sales of Beer Supported Results>0168.HK

26 mar. 2026, 22:00 UTC

Câștiguri

Tsingtao Brewery 2025 Rev CNY32.47B Vs. CNY32.14B >0168.HK

26 mar. 2026, 21:39 UTC

Achiziții, Fuziuni, Preluări

BlueScope: Sees Early Indications of Strong Interest in Site Adjacent Western Port

26 mar. 2026, 21:38 UTC

Achiziții, Fuziuni, Preluări

BlueScope: Has Begun Expression of Interest Process For 65-Hectare Site Adjacent Western Port

Comparație

Modificare preț

Quanterix Corp Așteptări

Obiectiv de preț

By TipRanks

89.39% sus

Prognoză pe 12 luni

Medie 7.5 USD  89.39%

Maxim 8 USD

Minim 7 USD

În baza a 2 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruQuanterix Corp - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

2 ratings

0

Cumpărare

2

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

5.34 / 6.015Suport & Rezistență

Termen scurt

Neutral Evidence

Termen mediu

Bullish Evidence

Termen lung

No Evidence

Sentiment

By Acuity

164 / 349 Clasament în Sănătate

Sentimentul știrilor

Neutral

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Quanterix Corp

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
help-icon Live chat